Olaratumab trial in soft tissue sarcoma fails to meet overall survival endpoint Presented ByDr William D. Tap, Memorial Sloan Kettering Cancer Centre, USA TrialPhase 3, ANNOUNCE ConferenceASCO 2019 TypePeer-reviewed article 15 July 2019 13:46